Nexgel Inc

NASDAQ:NXGLUnited States

NexGel, Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its gels and its consumer products are manufactured using proprietary and non-proprietary mixing, coating, and crosslinking technologies. It markets under the brand names MedaGel and LumaGel Beauty. The products it sells under its MedaGel brand primarily relate to over the counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications. The Company is also engaged in treating the symptoms of Psoriasis through its brand Kenkoderm.

Contact Information

Headquarters

2150 Cabot Boulevard West, Suite BLANGHORNE, PA, United States 19047

Phone

215-702-8550

Fax

302-636-5454

Executives

President, Chief Executive Officer

Adam Levy

Chief Financial Officer

Adam Drapczuk

Independent Director

Steven Mark Glassman

Independent Director

Scott Henry

Independent Director

Nachum Stein